Camurus AB (OSTO:CAMX) Operating Cash Flow per Share : kr10.75 (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Camurus AB Operating Cash Flow per Share?

Camurus AB's operating cash flow per share for the three months ended in Mar. 2024 was kr0.62. Camurus AB's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was kr10.75.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Camurus AB was 365.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Camurus AB's Operating Cash Flow per Share or its related term are showing as below:

During the past 13 years, Camurus AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 26.80% per year. The lowest was -260.60% per year. And the median was -7.15% per year.

OSTO:CAMX's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.3
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Camurus AB Operating Cash Flow per Share Historical Data

The historical data trend for Camurus AB's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Operating Cash Flow per Share Chart

Camurus AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-8.32

-4.37

-2.55

1.77

10.56

Camurus AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.42	1.16	8.45	0.52	0.62

Competitive Comparison of Camurus AB's Operating Cash Flow per Share

For the Biotechnology subindustry, Camurus AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Camurus AB's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Camurus AB's Price-to-Operating-Cash-Flow falls into.

Camurus AB Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Camurus AB's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	606.878	/	57.497
	=	10.55

Camurus AB's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	36.329	/	59.097
	=	0.61

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr10.75

Camurus AB Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Camurus AB's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Camurus AB (OSTO:CAMX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (OSTO:CAMX) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

7CA:Germany

Address

Ideon Science Park, Lund, SWE, SE-223 70

Website

https://www.camurus.com

Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032, and others. The company's geographical revenue includes Europe (of which Sweden), the United States of America, Australia, and Other geographical areas.